Suppr超能文献

非肽类血管紧张素 II 受体拮抗剂。N-[(杂芳基)甲基]咪唑的合成、体外活性及分子模拟研究

Nonpeptide angiotensin II receptor antagonists. Synthesis, in vitro activity, and molecular modeling studies of N-[(heterobiaryl)methyl] imidazoles.

作者信息

Salimbeni A, Canevotti R, Paleari F, Bonaccorsi F, Renzetti A R, Belvisi L, Bravi G, Scolastico C

机构信息

Medicinal Chemistry Department, Istituto Lusofarmaco, Milano, Italy.

出版信息

J Med Chem. 1994 Nov 11;37(23):3928-38. doi: 10.1021/jm00049a012.

Abstract

With the aim of explaining the influence of the structural changes on the biphenylic moiety on the activity, a series of N-[(heterobiaryl)methyl]imidazoles (I), constructed on the model of DuPont compounds by replacing either the central or terminal phenyl ring with a heteroaromatic one, such as furan, thiophene, thiazole, and pyridine, was synthesized. Compared to the reference DuPont compound (EXP-7711), all the heterobiaryl derivatives showed a reduced potency both in receptor binding (rat adrenal capsular membranes) and in the functional assay (angiotensin II-induced contraction of rabbit aorta strips). The lower activity was justified by the extensive molecular modeling studies, which took into consideration the conformational and electrostatic features of several heterobiaryl derivatives. On the basis of the results obtained, it was hypothesized that the central aromatic ring of the biarylic portion works as a spacer, orienting in the right way the terminal phenyl ring, whose electronic distribution is, instead, crucial to its fitting well with a lipophilic pocket at the receptor site.

摘要

为了解释联苯部分的结构变化对活性的影响,合成了一系列N-[(杂芳基)甲基]咪唑(I),该系列化合物以杜邦化合物为模型构建,通过用呋喃、噻吩、噻唑和吡啶等杂芳环取代中心或末端苯环。与参考杜邦化合物(EXP-7711)相比,所有杂芳基衍生物在受体结合(大鼠肾上腺包膜膜)和功能测定(血管紧张素II诱导的兔主动脉条收缩)中均显示出降低的效力。广泛的分子建模研究证实了较低的活性,该研究考虑了几种杂芳基衍生物的构象和静电特征。根据所得结果,推测联芳基部分的中心芳环起到间隔作用,以正确方式定向末端苯环,而末端苯环的电子分布对于其与受体部位的亲脂性口袋良好契合至关重要。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验